1. INTRODUCTION
1.1. Market Overview
1.2. Market Definition
1.3. Scope of the Study
1.4. Market Segmentation
1.5. Currency
1.6. Assumptions
1.7. Base and Forecast Years Timeline
1.8. Key Benefits to the Stakeholder
2. RESEARCH METHODOLOGY
2.1. Research Design
2.2. Research Processes
3. EXECUTIVE SUMMARY
3.1. Key Findings
4. MARKET DYNAMICS
4.1. Market Drivers
4.2. Market Restraints
4.3. Porter’s Five Forces Analysis
4.3.1. Bargaining Power of Suppliers
4.3.2. Bargaining Power of Buyers
4.3.3. Threat of New Entrants
4.3.4. Threat of Substitutes
4.3.5. Competitive Rivalry in the Industry
4.4. Industry Value Chain Analysis
4.5. Analyst View
5. GLOBAL NEUROPROSTHETICS MARKET BY TYPE
5.1. Introduction
5.2. Output Neural Prosthetics
5.2.1. Market Opportunities and Trends
5.2.2. Growth Prospects
5.2.3. Geographic Lucrativeness
5.3. Input Neural Prosthetics
5.3.1. Market Opportunities and Trends
5.3.2. Growth Prospects
5.3.3. Geographic Lucrativeness
6. GLOBAL NEUROPROSTHETICS MARKET BY TECHNIQUE
6.1. Introduction
6.2. Deep Brain Stimulation
6.2.1. Market Opportunities and Trends
6.2.2. Growth Prospects
6.2.3. Geographic Lucrativeness
6.3. Spinal Cord Stimulation
6.3.1. Market Opportunities and Trends
6.3.2. Growth Prospects
6.3.3. Geographic Lucrativeness
6.4. Sacral Nerve Stimulation
6.4.1. Market Opportunities and Trends
6.4.2. Growth Prospects
6.4.3. Geographic Lucrativeness
6.5. Transcranial Magnetic Stimulation
6.5.1. Market Opportunities and Trends
6.5.2. Growth Prospects
6.5.3. Geographic Lucrativeness
6.6. Vague Nerve Stimulation
6.6.1. Market Opportunities and Trends
6.6.2. Growth Prospects
6.6.3. Geographic Lucrativeness
7. GLOBAL NEUROPROSTHETICS MARKET BY APPLICATION
7.1. Introduction
7.2. Auditory Processing Disorders
7.2.1. Market Opportunities and Trends
7.2.2. Growth Prospects
7.2.3. Geographic Lucrativeness
7.3. Parkison’s Disease
7.3.1. Market Opportunities and Trends
7.3.2. Growth Prospects
7.3.3. Geographic Lucrativeness
7.4. Epilepsy
7.4.1. Market Opportunities and Trends
7.4.2. Growth Prospects
7.4.3. Geographic Lucrativeness
7.5. Ophthalmic Disease
7.5.1. Market Opportunities and Trends
7.5.2. Growth Prospects
7.5.3. Geographic Lucrativeness
7.6. Cardiovascular Disease
7.6.1. Market Opportunities and Trends
7.6.2. Growth Prospects
7.6.3. Geographic Lucrativeness
7.7. Paralysis
7.7.1. Market Opportunities and Trends
7.7.2. Growth Prospects
7.7.3. Geographic Lucrativeness
7.8. Alzheimer's Disease
7.8.1. Market Opportunities and Trends
7.8.2. Growth Prospects
7.8.3. Geographic Lucrativeness
7.9. Others
7.9.1. Market Opportunities and Trends
7.9.2. Growth Prospects
7.9.3. Geographic Lucrativeness
8. GLOBAL NEUROPROSTHETICS MARKET BY GEOGRAPHY
8.1. Introduction
8.2. North America
8.2.1. By Type
8.2.2. By Technique
8.2.3. By Application
8.2.4. By Country
8.2.4.1. USA
8.2.4.1.1. Market Opportunities and Trends
8.2.4.1.2. Growth Prospects
8.2.4.2. Canada
8.2.4.2.1. Market Opportunities and Trends
8.2.4.2.2. Growth Prospects
8.2.4.3. Mexico
8.2.4.3.1. Market Opportunities and Trends
8.2.4.3.2. Growth Prospects
8.3. South America
8.3.1. By Type
8.3.2. By Technique
8.3.3. By Application
8.3.4. By Country
8.3.4.1. Brazil
8.3.4.1.1. Market Opportunities and Trends
8.3.4.1.2. Growth Prospects
8.3.4.2. Argentina
8.3.4.2.1. Market Opportunities and Trends
8.3.4.2.2. Growth Prospects
8.3.4.3. Others
8.3.4.3.1. Market Opportunities and Trends
8.3.4.3.2. Growth Prospects
8.4. Europe
8.4.1. By Type
8.4.2. By Technique
8.4.3. By Application
8.4.4. By Country
8.4.4.1. Germany
8.4.4.1.1. Market Opportunities and Trends
8.4.4.1.2. Growth Prospects
8.4.4.2. France
8.4.4.2.1. Market Opportunities and Trends
8.4.4.2.2. Growth Prospects
8.4.4.3. United Kingdom
8.4.4.3.1. Market Opportunities and Trends
8.4.4.3.2. Growth Prospects
8.4.4.4. Others
8.4.4.4.1. Market Opportunities and Trends
8.4.4.4.2. Growth Prospects
8.5. Middle East and Africa
8.5.1. By Type
8.5.2. By Technique
8.5.3. By Application
8.5.4. By Country
8.5.4.1. Saudi Arabia
8.5.4.1.1. Market Opportunities and Trends
8.5.4.1.2. Growth Prospects
8.5.4.2. UAE
8.5.4.2.1. Market Opportunities and Trends
8.5.4.2.2. Growth Prospects
8.5.4.3. Others
8.5.4.3.1. Market Opportunities and Trends
8.5.4.3.2. Growth Prospects
8.6. Asia Pacific
8.6.1. By Type
8.6.2. By Technique
8.6.3. By Application
8.6.4. By Country
8.6.4.1. China
8.6.4.1.1. Market Opportunities and Trends
8.6.4.1.2. Growth Prospects
8.6.4.2. India
8.6.4.2.1. Market Opportunities and Trends
8.6.4.2.2. Growth Prospects
8.6.4.3. Japan
8.6.4.3.1. Market Opportunities and Trends
8.6.4.3.2. Growth Prospects
8.6.4.4. South Korea
8.6.4.4.1. Market Opportunities and Trends
8.6.4.4.2. Growth Prospects
8.6.4.5. Taiwan
8.6.4.5.1. Market Opportunities and Trends
8.6.4.5.2. Growth Prospects
8.6.4.6. Thailand
8.6.4.6.1. Market Opportunities and Trends
8.6.4.6.2. Growth Prospects
8.6.4.7. Indonesia
8.6.4.7.1. Market Opportunities and Trends
8.6.4.7.2. Growth Prospects
8.6.4.8. Others
8.6.4.8.1. Market Opportunities and Trends
8.6.4.8.2. Growth Prospects
9. COMPETITIVE ENVIRONMENT AND ANALYSIS
9.1. Major Players and Strategy Analysis
9.2. Market Share Analysis
9.3. Mergers, Acquisitions, Agreements, and Collaborations
9.4. Competitive Dashboard
10. COMPANY PROFILES
10.1. SenArs
10.2. LivaNova PLC
10.3. Medtronic PLC
10.4. Sonova Holding AG
10.5. Boston Scientific Corporation
10.6. Cochlear Ltd
10.7. Demant AS
10.8. Abbott Laboratories
10.9. NeuroPace, Inc.
10.10. BrainGate
10.11. NDI Medical